Neurocrine Biosciences, Inc. (NBIX) Insider Trading
Over the last 3 months, NBIX insiders made 0 open-market buys and 22 sales, a net sale of -$19.3M (SEC Form 4). Over the last 6 months, 616 institutions increased and 454 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
22
Net (3m)
-$19.3M
Insider trades by month Buys Sells
Nov
Dec
Jan
May
Jun
Jul
Context3-month price -2.5%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 30, 2026 | Norwalk Leslie Vdirector | Sell | 1,250 | $182.01 |
| Jul 30, 2026 | Norwalk Leslie Vdirector | Option | 842 | $139.43 |
| Jul 13, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Option | 4,367 | $106.02 |
| Jul 13, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Option | 10,000 | $81.49 |
| Jul 13, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Sell | 10,000 | $179.60 |
| Jul 13, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Sell | 4,367 | $181.02 |
| Jul 9, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Option | 8,433 | $103.52 |
| Jul 9, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Option | 2,737 | $103.52 |
| Jul 9, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Sell | 8,433 | $178.72 |
| Jul 9, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Sell | 2,737 | $178.54 |
| Jul 9, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Option | 3,401 | $103.52 |
| Jul 9, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Sell | 3,401 | $178.57 |
| Jun 30, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Option | 200 | $81.49 |
| Jun 30, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Sell | 200 | $169.56 |
| Jun 30, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Option | 1,690 | $81.49 |
| Jun 30, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Sell | 1,690 | $170.81 |
| Jun 30, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Sell | 8,110 | $170.03 |
| Jun 30, 2026 | Lippoldt Darinofficer: Chief Legal Officer | Option | 8,110 | $81.49 |
| Jun 9, 2026 | SHERWIN STEPHEN Adirector | Sell | 1,843 | $167.31 |
| Jun 9, 2026 | SHERWIN STEPHEN Adirector | Sell | 2,549 | $164.44 |
| Jun 9, 2026 | SHERWIN STEPHEN Adirector | Sell | 6,896 | $165.79 |
| Jun 9, 2026 | SHERWIN STEPHEN Adirector | Sell | 5,829 | $166.56 |
| Jun 9, 2026 | SHERWIN STEPHEN Adirector | Sell | 7,883 | $163.81 |
| Jun 9, 2026 | SHERWIN STEPHEN Adirector | Option | 10,000 | $79.79 |
| Jun 9, 2026 | SHERWIN STEPHEN Adirector | Option | 15,000 | $53.64 |
| Jun 8, 2026 | Norwalk Leslie Vdirector | Sell | 1,250 | $168.06 |
| Jun 4, 2026 | Keswani Sanjay Chandruofficer: Chief Medical Officer | Option | 3,212 | — |
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Sell | 14,214 | $154.83 |
| Jun 4, 2026 | Keswani Sanjay Chandruofficer: Chief Medical Officer | Tax | 1,733 | $154.84 |
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Sell | 9,521 | $157.62 |
Source: NBIX SEC Form 4 filings, latest Jul 30, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their NBIX positions over the last 6 months (SEC Form 13F).
Increased
616
New positions
237
Reduced
454
Sold out
69
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 13.7M | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 13.4M | May 13, 2026 |
| JPMORGAN CHASE & CO | Increased | 6.4M | Aug 12, 2026 |
| DODGE & COX | Increased | 5.6M | Aug 13, 2026 |
| DODGE & COX | Reduced | 5.5M | May 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 5.4M | May 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 5.0M | Aug 13, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 4.9M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4.7M | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4.5M | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4.5M | May 15, 2026 |
| STATE STREET CORP | Increased | 4.4M | Aug 7, 2026 |
| STATE STREET CORP | Increased | 4.4M | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 3.8M | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 3.1M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.